Strength
450 mg/1
Manufacturer
Melinta Therapeutics, LLCNDC
70842010102
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/19/2024
Active Ingredients
DELAFLOXACIN MEGLUMINEApproval Type
New Drug (NDA)
FDA Application
NDA208610On Market Since
6/19/2017
Pharmacological Classes
Fluoroquinolone Antibacterial
Fluoroquinolones